Nasir Syed
Pulmonary Disease · Live Oak, TXNPI 1659373868
Payments from drug & device makers
Across 146 payments — averaging $20.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$846
- Boehringer Ingelheim$477
- Actelion Pharmaceuticals US, Inc.$371
- AstraZeneca$324
- GSK$194
- Grifols USA, LLC$185
- plus $584 from 13 others
What the payments were for
- Travel & lodging$79026%
- Food & beverage$2,14672%
- Education$462%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation Of The Americas | 7 | $846 |
| Boehringer Ingelheim | 31 | $477 |
| Actelion Pharmaceuticals US, Inc. | 29 | $371 |
| AstraZeneca | 19 | $324 |
| GSK | 15 | $194 |
| Grifols USA, LLC | 12 | $185 |
| Jazz Pharmaceuticals Inc. | 6 | $129 |
| Sanofi | 5 | $109 |
| Sunovion Pharmaceuticals Inc. | 6 | $75 |
| Resmed Corp | 2 | $46 |
| United Therapeutics Corporation | 3 | $44 |
| Philips North America LLC | 3 | $38 |
| Stimwave Technologies Incorporated | 1 | $35 |
| Mylan Specialty L.p. | 2 | $28 |
| Gilead | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $14 |
| Antares Pharma, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,982 in reported general payments places this provider in the 50th percentile of 904 pulmonary disease providers in Texas.
Other pulmonary disease in Live Oak
- Charles AndrewsSan Antonio$17M
- Ivan RosasHouston$13.8M
- Shahrukh KureishyMcKinney$12.4M
- Raksha JainDallas$3.4M
- Kelly ChinDallas$2.7M
- Julie PhilleyTyler$2.4M
- Nicola HananiaHouston$2.2M
- Sandeep SahayHouston$2.1M
- Antonio AnzuetoSan Antonio$1.8M
- Diego Maselli CaceresSan Antonio$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.